New York, NY – April 25, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today first patient enrolled in a pilot study collecting patient-generated health data...
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the publication of a new multi-domain model for capturing functional status in oncology through connected digital tools...
Read More
When smartphone-powered fitness trackers emerged, clinical researchers, life science professionals, and academic researchers immediately saw the potential for real-time data synchronization and data summary visualizations for end users.1 Their interest…
Recently, the Food and Drug Administration (FDA) and American Society of Clinical Oncology (ASCO) held a joint virtual workshop on clinical outcome assessments in clinical trials for cancer treatments. This…
As part of Koneksa’s participation in the recent Immuno-Oncology Conference (IO360), CEO Chris Benko summarized Koneksa’s work in oncology. In the often technical world of oncology research, the human patients…
Koneksa Health enables oncology research at Montefiore Einstein Center for Cancer Care by facilitating the collection and visualization of activity data from Garmin vivofit® devices. NEW YORK, NY (PRWEB)...
Read More
